Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 4 of 4)
This article was originally published in The Pink Sheet Daily
Executive Summary
Can drug companies, government and academia solve the big problems together without cries of conflicted interest?
You may also be interested in...
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 3 of 4)
Panelists discuss asset valuation, the scarcity of viable candidates in some parts of the neuro sector and the need for novel ways of funding early development.
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps (part 2 of 4)
In part II of a series, panelists discuss venture capital, NIH grants, SBIR and foundation funding, as ways to support discovery.
Industry Roundtable: Neurotech Execs Discuss Innovation, Challenges, Next Steps
In Part I of a series, panelists discuss outcomes measures in a sector with unique regulatory conditions and the need for biomarkers.